Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bharat, UW-Madison, FluGen Pursue Intranasal COVID-19 Vaccine

Trial Start Expected In August-October

Apr 06 2020

• By Vibha Ravi

Biochemistry — Vaccine Has Part Of SARS-CoV-2 Spike Protein Coding Region Added To M2SR • Source: Shutterstock

Related Content

NanoBio Nasal Antiseptic Launch Accelerated As COVID-19 Spikes Demand For Personal Sanitizers

Apr 05 2020

Bharat Enters Chikungunya Fray As Vaccine Moves Into Trials

Jun 09 2017

CureVac Denies Takeover Reports As It Slates Phase I Coronavirus Vaccine Study For Early Summer

Mar 18 2020

Race On: China Starts Coronavirus Vaccine Trial, Vows Fast Development

Mar 23 2020

Sanofi Joins mRNA COVID-19 Club With Translate Tie-Up

Mar 27 2020

COVID-19 Vaccine Could Cost As Little As $10 A Dose, Says Janssen

Apr 02 2020

Related Companies

Bharat Biotech

Sanofi

BioNTech SE

Moderna, Inc.

BlueWillow Biologics

CanSino Biologics Inc.

Johnson & Johnson

FluGen Inc.

Additional Topics

India Asia Pacific United States Coronavirus COVID-19 Research & Development Vaccines Clinical Trials BioPharmaceutical

More from COVID-19

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window